Boston Scientific Corp (BSX)
87.60
-1.17
(-1.32%)
USD |
NYSE |
Nov 14, 16:00
87.60
0.00 (0.00%)
After-Hours: 18:02
Boston Scientific Research and Development Expense (Quarterly): 407.00M for Sept. 30, 2024
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 407.00M |
| June 30, 2024 | 383.00M |
| March 31, 2024 | 366.00M |
| December 31, 2023 | 363.00M |
| September 30, 2023 | 356.00M |
| June 30, 2023 | 359.00M |
| March 31, 2023 | 337.00M |
| December 31, 2022 | 330.00M |
| September 30, 2022 | 339.00M |
| June 30, 2022 | 335.00M |
| March 31, 2022 | 319.00M |
| December 31, 2021 | 320.00M |
| September 30, 2021 | 310.00M |
| June 30, 2021 | 298.00M |
| March 31, 2021 | 276.00M |
| December 31, 2020 | 286.00M |
| September 30, 2020 | 315.00M |
| June 30, 2020 | 242.00M |
| March 31, 2020 | 300.00M |
| December 31, 2019 | 308.00M |
| September 30, 2019 | 306.00M |
| June 30, 2019 | 280.00M |
| March 31, 2019 | 280.00M |
| December 31, 2018 | 288.00M |
| September 30, 2018 | 289.00M |
| Date | Value |
|---|---|
| June 30, 2018 | 275.00M |
| March 31, 2018 | 261.00M |
| December 31, 2017 | 263.00M |
| September 30, 2017 | 254.00M |
| June 30, 2017 | 244.00M |
| March 31, 2017 | 235.00M |
| December 31, 2016 | 256.00M |
| September 30, 2016 | 232.00M |
| June 30, 2016 | 222.00M |
| March 31, 2016 | 210.00M |
| December 31, 2015 | 244.00M |
| September 30, 2015 | 221.00M |
| June 30, 2015 | 220.00M |
| March 31, 2015 | 192.00M |
| December 31, 2014 | 208.00M |
| September 30, 2014 | 212.00M |
| June 30, 2014 | 206.00M |
| March 31, 2014 | 191.00M |
| December 31, 2013 | 217.00M |
| September 30, 2013 | 217.00M |
| June 30, 2013 | 223.00M |
| March 31, 2013 | 204.00M |
| December 31, 2012 | 238.00M |
| September 30, 2012 | 220.00M |
| June 30, 2012 | 213.00M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
242.00M
Minimum
Jun 2020
407.00M
Maximum
Sep 2024
327.45M
Average
325.00M
Median
Research and Development Expense (Quarterly) Benchmarks
| Baxter International Inc | 129.00M |
| Haemonetics Corp | 16.53M |
| ResMed Inc | 79.52M |
| Abbott Laboratories | 713.00M |
| Globus Medical Inc | 35.38M |